| 0 | ℹ |
CD4(+) T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.
(nature.com)
|
Nature Medicine 2026-02-01 | #inflammation #immunotherapy #car-t #toxicity #myeloma |